Revvity Signals || Signals One™

EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Using Mass Spectrometry as Quality Control in Medicinal Cannabis

    Cannabis plants contain a wide variety of complex compounds including phytocannabinoids terpenoids and flavonoids found mainly in the inflorescences Major phytocannabinoids like CBD and THC have beneficial effects on human health

    Maximizing ROI: The Secret to Successful Pharma Magazine Advertising

    Advertisement through pharma magazines has for a long time remained common in most marketing strategies for pharma industries Its been around and it provides the best chance to engage with pharma professional other industry players and even a wellinformed populace However more especially given that the modern world is a digital realm there are always issues pertaining to the effectiveness of such...

    Pain Points and Progress: Navigating the Complexities of Life Sciences Logistics

    Within recent years there has been a new facet of complexity in the supply chain pathways of the life sciences industry From rising geopolitical tensions to trade wars logistics teams now have to operate in an environment shaped by rapid change regulatory scrutiny and unpredictable policy changes influenced by politics

    How M&A Is Reshaping Europe’s Pharmaceutical Pipeline

    For most of the past halfcentury a European drugmakers future was written in its own laboratories That model has not disappeared but it has been joined and in many boardrooms overtaken by a second engine of growth the acquisition of externally discovered science

    Implementing Quality by Design (QbD) in Pharmaceutical Development: Enhancing Product Quality and Regulatory Compliance

    Quality by Design QbD stands as a systematic strategy for pharmaceutical development prioritizing predefined product objectives and emphasizing a thorough understanding of both the product and its manufacturing processes This proactive approach integrates quality seamlessly into the development process championing a sciencedriven

    Pharma ABM Strategies for B2B Growth: Precision Targeting for Key Accounts

    The pharmaceutical industry is making significant strides changing the way that company ies are identified engaged and converted into high value business customers In todays datadriven competitive world traditional mass marketing strategies are no longer effective In todays day and age pharmaceutical companies are embracing very personalized relationships ROI measurement and the expansion of their...

TOP ARTICLES

press releases Read more...

Enveda Collaborates with Anthropic to Accelerate Drug Development

Enveda a biotechnology company using AI to translate natures chemistry into new medicines today announced results from its collaboration with Anthropic to streamline critical documentation processes in drug development Working with Claude Enveda developed AIenabled workflows to review Good Manufactu...

Pythia Labs Launches with AI-Designed Antibodies for Hard-to-Drug Targets

Pythia Labs a biotechnology company building frontier AI models for therapeutic discovery today announced its launch alongside a preprint in bioRxiv introducing Pythia the allatom generative model at the core of its antibody design platform Pythias technology is built to create antibodies against ta...

Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

Genmab AS and Incyte announced a clinical trial collaboration to evaluate petosemtamab Genmabs investigational IgGbispecific antibody targeting the epidermal growth factor receptor EGFR and leucinerich repeat containing Gproteincoupled receptor LGR in combination with INCB Incytes investigational p...

CasZyme and Cirena to Collaborate on Developing Longer Guide RNAs to Optimise Cas12l Performance

CasZyme and Cirena have today signed an agreement that will see the two companies collaborate on further optimising the editing efficiency of CasZymes Casl CRISPR nuclease in humanrelevant applications using Cirenas synthetic nt guide RNAs

28 - 30

Oct 2026

02 - 04

Nov 2026

Pharma Forum EMEA 2026

Dom Pedro Lisboa Hotel, Lisbon...

02 - 04

Nov 2026

Cancer R&D 2026

Houston, TX, USA

03 - 05

Nov 2026

10th Dermatology Drug Development

Boston, Massachusetts at The C...

03 - 04

Nov 2026

PDA Aseptic Processing of Biopharma Conference

Sheraton Grand Incheon Hotel,...

04 - 05

Nov 2026

Advanced Therapies USA

Hynes Convention Center, Bosto...

05 - 05

Nov 2026

PDA Contamination Control Strategy Workshop

Sheraton Grand Incheon Hotel,...

09 - 11

Nov 2026

11th Microbiome Movement USA Summit

The Colonnade Hotel, Boston, M...

LATEST NEWS Read more...

Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma

Roche announced today the global launch of the VENTANA BAP SP test This automated readytouse immunohistochemistry IHC assay provides a reliable highly specific diagnostic tool to help clinicians and pathologists accurately identify mesothelioma and distinguish it from other malignancies including no...

Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection

Stevanato Group SpA a leading global provider of drug containment drug delivery and diagnostic solutions to the pharmaceutical biotechnology and life sciences industries today announced a collaboration with Aptar Pharma to provide systemlevel data supporting earlier evaluation of prefilled syringe c...

Sacituzumab Tirumotecan (Sac-TMT) Reduced the Risk of Death by 32% and the Risk of Disease Progression or Death by 41% Compared to Chemotherapy in Patients With Recurrent Endometrial Cancer

Merck known as MSD outside of the United States and Canada today announced the first presentation of results from the pivotal Phase TroFuse trial evaluating sacituzumab tirumotecan sacTMT an investigational TROPdirected antibodydrug conjugate ADC being developed in collaboration with KelunBiotech i...

Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling

Tempus AI Inc announced that its xR assay has received certification under the European Unions In Vitro Diagnostic Regulation IVDR as a Class C in vitro diagnostic device The certification covers Tempus quality management system for nextgeneration sequencing devices for cancer genomic profiling to s...

Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent

The Menarini Group a leading international pharmaceutical and diagnostics company and Stemline Therapeutics Inc Stemline a whollyowned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients along with Georgiamune Inc a clinicalstage biotechnology...

LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical and GLP Bioanalytical Services

LGM Pharma a leading provider of tailored API sourcing contract analytical testing and drug development services today announced it has acquired Sannova Analytical a contract research laboratory headquartered in Somerset NJ The acquisition expands LGM Pharmas analytical testing services business by...